Upon examining the association of the CYP2B6*9 (G516T) polymorphism with B-CLL, we observed that the median age of the disease onset was significantly lower in the (GT) and (TT) groups than the (GG) group (p < 0.001). The gene discussed is CYP2B6; the disease is B-cell chronic lymphocytic leukemia.